Dynamics Special Purpose Corp.
Status: Deal Closed
U=S
| IPO Proceeds, $M | $230.00M |
|---|---|
| IPO Date | May 26, 2021 |
| CEO | Mostafa Ronaghi |
| Left Lead | JP Morgan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Companies across the emerging healthcare value chain, life sciences tools, enabling-software, synthetic biology and novel drug discovery and development platforms that enable applications in prevention, diagnosis, treatment and advanced bio-materials |
| IPO Geography | US/Canada |
| Target Company | Senti Bio |
| Deal Announced | Dec 20, 2021 |
| Deal Size, $M | $276.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Jun 7, 2022 |
| Amendment Vote | TBD |
| Closing Date | Jun 8, 2022 |
Formerly DYNS
SNTI
| Price | $0.30 |
|---|---|
| Last closing price | $0.30 |
| H/L, today | $0.28 / $0.31 |
| H/L, 52-week | $0.27 / $2.73 |
| Volume, today | 50,816 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Dynamics Special Purpose Corp.:
- Structure and cap table
- 7 directors & officers
- 20 filings and events
- 1 underwriters
- 6 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Omid Farokhzad | 52 | Executive Chair & Director |
| Mostafa Ronaghi | 52 | CEO & Director |
| Mark Afrasiabi | 45 | CFO |
| Rowan Chapman | 50 | CBO |
| David Epstein | 59 | Director |
| Jay Flatley | 68 | Director |
| Deep Nishar | 52 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| JP Morgan | BR | 20,000,000 | units |
| 20,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 20 filings.